• Roche-AbbVie cancer drug gets accelerated FDA approval expressbpd
    November 24, 2018
    Roche Holding said its cancer drug, Venclexta, received accelerated approval from the US Food and Drug Administration as part of a combination treatment for newly diagnosed patients with a form of leukemia.
PharmaSources Customer Service